11 Best NYSE Penny Stocks to Buy Right Now

Page 9 of 10

2. Nuvation Bio Inc. (NYSE:NUVB)

Price as of October 31: $2.34

Number of Hedge Fund Holders: 35

Nuvation Bio Inc. (NYSE:NUVB) is a clinical-stage biopharmaceutical company that develops therapeutic candidates for oncology. Its lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation. It is one of the best NYSE penny stocks to buy right now, going by its robust pipeline of drug candidates in various stages of development targeting unmet medical needs.

Taletrectinib is a candidate drug that has already shown competitive efficacy and safety in clinical trials on the treatment of non-small cell lung cancer. Nuvation Bio Inc. (NYSE:NUVB) is submitting a new drug application for the candidate drug as it aims to commercialize it as early as next year upon regulatory approval.

The positive clinical data indicate the strong potential for Taletrectinib to generate long-term shareholder value. Likewise, Nuvation Bio Inc. (NYSE:NUVB) addresses unmet medical needs in oncology and rare disease positions for long-term success.

Page 9 of 10